UCA1 was involved in BC progression through the activation of the oncogenic PI3K-AKT-mTOR pathway, positively regulating glutaminase 2 (GLS2) expression, upregulating expression of high mobility group protein B1 (HMGB1) and downregulating p21 expression (22). Here, UCA1 is linked to breast cancer.